Latest Clario News & Updates

See the latest news and media coverage for Clario. We track all announcements, press releases, and industry mentions in real time, all in one place.

Clario

Clinical trial endpoint technology and services provider

Latest news about Clario

February 26 Clario

Clario study shows speech-latency biomarker strengthens schizophrenia trial separation

Research in Biological Psychiatry reveals excluding high placebo responders via speech latency boosts drug-placebo separation 2-3 times in brilaroxazine Phase III trial. Clario’s Chief Research Officer Mark Opler co-investigated.
February 18 Clario

Clario achieves ISO 42001 certification for AI management

The certification, audited by Schellman, underscores Clario's leadership in responsible AI for clinical trials, complementing ISO 27701 and 27001 standards.
January 19 Clario

NICE publishes draft guidance recognizing Clario's AI-supported spirometry

The guidance highlights ArtiQ.Spiro's potential to enable high-quality testing in primary care, expand access, and reduce waiting times.
3 December 2025 Clario

Clario announces Gaurav Josan's Responsible Tech Leader Award win

He received it at the 2025 WLDA Awards Gala for embedding transparency, ethics, and equity in AI systems. His work advances responsible AI in clinical trials.

April 27 Morningstar

CLARIO GROUP LAUNCHES XROI™, A PROPRIETARY AI-ENABLED FRAMEWORK FOR EVALUATING EXECUTIVE REPUTATION,...

XROI™ anchors a broader suite of AI-powered solutions designed to elevate leadership performance and organizational impactNEW YORK, April 27, 2026 /PRNewswire/ -- Clario Group today...
April 26 MSN

Thermo Fisher lifts 2026 forecast after Clario deal, AI tie-ups

Thermo Fisher Scientific raised its 2026 revenue forecast to $47.3-$48.1 billion and adjusted EPS to $24.64-$25.12 after a strong first quarter and the completion of...
March 30 New Straits Times

Thermo Fisher nears US$10 billion takeover of Clario, FT reports

BENGALURU: Medical equipment maker Thermo Fisher is nearing an all-cash takeover of US-based Clario in a deal that could value the clinical trial data management...
March 24 The Globe and Mail

Thermo Fisher Completes Strategic Acquisition of Clario Holdings

Thermo Fisher ( (TMO)) just unveiled an announcement. On March 24, 2026, Thermo Fisher Scientific announced it had completed the $8.875 billion cash acquisition of...

Never miss news about Clario

Track Clario and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.